Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Murine lupus genetics: lessons learned.

C Mohan1

  • 1Department of Internal Medicine/Rheumatology, Simmons Arthritis Research Center, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8884, USA. Chandra.mohan@utsouthwestern.edu

Current Opinion in Rheumatology
|October 18, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined cyclosporine A and urolithin A therapy ameliorates murine lupus nephritis.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Leveraging Lymphatic System Targeting in Systemic Lupus Erythematosus for Improved Clinical Outcomes.

Pharmacological reviews·2024
Same author

Comparison of the Aotearoa New Zealand Early Warning Score and National Early Warning Score to predict adverse inpatient events in a vital sign dataset.

Anaesthesia·2023
Same author

Comparison of the Aotearoa New Zealand Early Warning Score and National Early Warning Score to predict adverse inpatient events in a vital sign dataset.

Anaesthesia·2023
Same author

VASCULAR EMBOLOTHERAPY-HOW MUCH HAS BEEN ACHIEVED?

Medical journal, Armed Forces India·2017
Same author

RADIOLOGICAL QUIZ.

Medical journal, Armed Forces India·2017
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Systemic lupus erythematosus (SLE) is a complex autoimmune disease influenced by numerous genes. Understanding these genetic factors and their interactions is crucial for developing effective lupus treatments.

Area of Science:

  • Immunology
  • Genetics
  • Autoimmune Diseases

Background:

  • Systemic lupus erythematosus (SLE) is a complex autoimmune disease with a poorly understood genetic basis.
  • Previous studies have identified numerous genetic loci associated with lupus susceptibility in mice.

Purpose of the Study:

  • To synthesize findings from reverse and forward genetic studies in murine lupus models.
  • To identify key genetic pathways and molecular checkpoints contributing to lupus pathogenesis.

Main Methods:

  • Analysis of recent reverse genetic studies in murine lupus models.
  • Integration of findings from forward genetic studies identifying relevant molecular pathways.

Main Results:

  • Lupus is highly polygenic, with single loci affecting multiple phenotypes and epistatic interactions creating novel autoimmune traits.

Related Experiment Videos

  • Susceptibility loci often co-cluster with other autoimmunity loci and involve subtle polymorphic alleles rather than major mutations.
  • Forward genetics implicates molecules in apoptosis, apoptotic cell clearance, B-cell and T-cell function, and end-organ pathology.

    • Conclusions:

    • Genetic factors contributing to lupus can be categorized into distinct pathways.
    • Further research is needed to delineate the molecular mediators of these lupus-associated checkpoints.